193 related articles for article (PubMed ID: 12214891)
1. Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma.
Chhabra SK; Pandey KK
J Asthma; 2002 Aug; 39(5):375-81. PubMed ID: 12214891
[TBL] [Abstract][Full Text] [Related]
2. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.
Lanes SF; Garrett JE; Wentworth CE; Fitzgerald JM; Karpel JP
Chest; 1998 Aug; 114(2):365-72. PubMed ID: 9726716
[TBL] [Abstract][Full Text] [Related]
3. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction.
Barros MJ; Rees PJ
Respir Med; 1990 Sep; 84(5):371-5. PubMed ID: 2147295
[TBL] [Abstract][Full Text] [Related]
4. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.
Britton J; Hanley SP; Garrett HV; Hadfield JW; Tattersfield AE
Thorax; 1988 Apr; 43(4):300-5. PubMed ID: 2970125
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department.
Browne GJ; Trieu L; Van Asperen P
Crit Care Med; 2002 Feb; 30(2):448-53. PubMed ID: 11889328
[TBL] [Abstract][Full Text] [Related]
6. Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials.
Haney S; Hancox RJ
Respir Res; 2007 Mar; 8(1):19. PubMed ID: 17341317
[TBL] [Abstract][Full Text] [Related]
7. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study.
Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ
Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
Donohue JF; Wise R; Busse WW; Garfinkel S; Zubek VB; Ghafouri M; Manuel RC; Schlenker-Herceg R; Bleecker ER
BMC Pulm Med; 2016 Apr; 16(1):65. PubMed ID: 27130202
[TBL] [Abstract][Full Text] [Related]
9. Comparison of salbutamol and ipratropium bromide versus salbutamol alone in the treatment of acute severe asthma.
Hossain AS; Barua UK; Roy GC; Sutradhar SR; Rahman I; Rahman G
Mymensingh Med J; 2013 Apr; 22(2):345-52. PubMed ID: 23715360
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J
Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820
[TBL] [Abstract][Full Text] [Related]
11. Salbutamol but not ipratropium abolishes leukotriene D4-induced gas exchange abnormalities in asthma.
Dahlén B; Gómez FP; Casas A; Howarth PH; Dahlén SE; Rodriguez-Roisin R
Eur J Clin Pharmacol; 2012 Oct; 68(10):1375-83. PubMed ID: 22457014
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation.
Goggin N; Macarthur C; Parkin PC
Arch Pediatr Adolesc Med; 2001 Dec; 155(12):1329-34. PubMed ID: 11732951
[TBL] [Abstract][Full Text] [Related]
13. Nebulized ipratropium in the treatment of acute asthma.
Summers QA; Tarala RA
Chest; 1990 Feb; 97(2):425-9. PubMed ID: 2137076
[TBL] [Abstract][Full Text] [Related]
14. Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD.
Norris V; Ambery C
Pulm Pharmacol Ther; 2013 Oct; 26(5):574-80. PubMed ID: 23524017
[TBL] [Abstract][Full Text] [Related]
15. The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD.
Singh D; Abbott-Banner K; Bengtsson T; Newman K
Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30166326
[TBL] [Abstract][Full Text] [Related]
16. A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma.
Karpel JP; Schacter EN; Fanta C; Levey D; Spiro P; Aldrich T; Menjoge SS; Witek TJ
Chest; 1996 Sep; 110(3):611-6. PubMed ID: 8797400
[TBL] [Abstract][Full Text] [Related]
17. Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma.
Garrett JE; Town GI; Rodwell P; Kelly AM
J Allergy Clin Immunol; 1997 Aug; 100(2):165-70. PubMed ID: 9275135
[TBL] [Abstract][Full Text] [Related]
18. Relative and additional bronchodilator response of salbutamol and ipratropium in smoker and nonsmoker asthmatics.
Ahmad Z; Singh SK
J Asthma; 2010 Apr; 47(3):340-3. PubMed ID: 20394521
[TBL] [Abstract][Full Text] [Related]
19. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
Pauwels R; Joos GF; Fogarty C; Faiferman I; Hirschberg S; Vessey R; Wouters EF
Pulm Pharmacol Ther; 2008; 21(2):385-92. PubMed ID: 18023600
[TBL] [Abstract][Full Text] [Related]
20. The effects of the combination of inhaled ipratropium and oral theophylline in asthma.
Burki NK
Chest; 1997 Jun; 111(6):1509-13. PubMed ID: 9187165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
